1122
STUDY DESIGN : We combined paclitaxel , melphalan and high - dose cyclophosphamide , thiotepa , and carboplatin in a triple sequential high - dose regimen for patients with metastatic breast cancer .
 paclitaxel, melphalan, cyclophosphamide, thiotepa, carboplatin, breast cancer
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 paclitaxel, melphalan, cyclophosphamide, thiotepa, carboplatin, breast cancer